Kangtai Biological has been named to the 2018 Top 10 Chinese Biopharmaceutical Companies list.

Release date:

2019-07-23

Author:

Source:


Abstract

On July 15, the “2018 China Top 100 Pharmaceutical Companies Series Rankings,” compiled by the Expert Committee of the China Top 100 Pharmaceutical Companies List, were released. Kangtai Biological ranked 7th on the “Top 20 Chinese Biopharmaceutical Enterprises (including blood products, vaccines, insulin, etc.)” list.

  On July 15, the “2018 China Top 100 Pharmaceutical Companies Series Rankings,” compiled by the Expert Committee of the China Top 100 Pharmaceutical Companies List, were released. Kangtai Biological ranked 7th on the “Top 20 Chinese Biopharmaceutical Enterprises (including blood products, vaccines, insulin, etc.)” list.

 

 

  According to reports, the ranking was compiled by an expert committee and based on quantitative analysis using the Minenet database of the three major terminals and the six‑market terminal structure. It arrives at a scientific and rigorous assessment of pharmaceutical companies across two key dimensions: innovation-driven momentum and professional promotion capabilities.

 

 

  Given that the core competitive factors vary across the major sub‑sectors of China’s pharmaceutical industry, a forced horizontal comparison is not feasible. In line with expert input, this ranking does not feature an overall list; instead, it comprises five specialized sub‑rankings: the “Top 100 Chinese Chemical Pharmaceutical Companies,” the “Top 100 Chinese Traditional Chinese Medicine Companies,” the “Top 20 Chinese CRO (including CDMO) Companies,” the “Top 20 Chinese Medical Device (including IVD) Companies,” and the “Top 20 Chinese Biopharmaceutical (including blood products, vaccines, insulin, etc.) Companies.”

 

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09